Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Morpholine | HCID 8083 | — |
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | HCID 68740138 | HCID 68740138 | — |
| Reactant | HCID 178484293 | HCID 178484293 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 57635016 | HCID 57635016 | — |
Reaction Steps
A mixture of 0.04 g (0.000095 mole) of 4-(9-cyclohexyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-methoxy-benzoic acid (I-28a), 0.055 g (0.00015 mole) of 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium-3-oxide hexafluorophosphate, 0.015 mL (0.00017 mole) of morpholine, 0.04 mL of triethylamine and 2 mL of dichloromethane was stirred overnight at ambient temperature. The mixture was washed with 1 mL of water then with 1.1 mL of 0.34 M sodium hydroxide. The dichloromethane layer was concentrated under reduced pressure, and the residue purified by C18 reverse phase silica gel chromatography, eluting with an acetonitrile-water gradient (10:90-100:0) to give 0.0069 g of 9-cyclohexyl-2-[2-methoxy-4-(morpholine-4-carbonyl)-phenylamino]-5,7,8,9-tetrahydro-pyrimido[4,5-b][1,4]diazepin-6-one (I-31)
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07517873B2 |
|---|
| Source dataset | uspto-grants-2009_04 |
|---|
| ORD ID | ord-16bc5a2e8d74452a88ad47d19a19ddee |
|---|
| Source note | uspto-grants-2009_04 |
|---|